Clinical Trial Update: ATG Plus PTCy vs ATG for CGVHD Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ATG plus post-transplant cyclophosphamide versus ATG for prophylaxis of chronic graft-versus-host disease in patients with acute leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• ATG (anti-thymocyte globulin)
• post-transplant cyclophosphamide (cyclophosphamide)

Snippet

Sponsor: McMaster University | Conditions: Acute Leukemia, Myelodysplasia | Phase 2 | Status: ACTIVE_NOT_RECRUITING